Dr. Agarwal's Eye Hospital share price

High risk
  • 60%Low risk
  • 60%Moderate risk
  • 60%Balanced risk
  • 60%High risk
  • 60%Extreme risk
  • 4,175.10(-0.69%)
    April 30, 2025 10:09:28 AM IST
    • NSE
    • BSE
  • Vol : 0.12K (NSE + BSE)
    Last 20 day avg : 1.64 K

Dr. Agarwal's Eye Hospital is trading -0.69% lower at Rs 4,175.10 as compared to its last closing price. Dr. Agarwal's Eye Hospital has been trading in the price range of 4,294.95 & 4,161.05. Dr. Agarwal's Eye Hospital has given -31.61% in this year & -2.45% in the last 5 days. Dr. Agarwal's Eye Hospital has TTM P/E ratio 56.15 as compared to the sector P/E of 22.89.There are 1 analysts who have initiated coverage on Dr. Agarwal's Eye Hospital. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 10.40 Crores in its last quarter.Listed peers of Dr. Agarwal's Eye Hospital include Krsnaa Diagnostics (-0.28%), Shalby (-1.05%), Dr. Agarwal's Eye Hospital (-0.69%).The Mutual Fund holding in Dr. Agarwal's Eye Hospital was at 0.05% in 31 Dec 2024. The MF holding has - from the last quarter. The FII holding in Dr. Agarwal's Eye Hospital was at 0.84% in 31 Dec 2024. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 30, 2025, 04:40 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.12
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    12.57
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    38.41
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.11
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.71
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
4,161.05
Highest
4,294.95
52 week range
Lowest
2,800.00
Highest
7,300.00
Dr. Agarwal's Eye Hospital Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 25.69% from Rs 95.11 crore to Rs 75.67 crore, year-on-year
    • financial-insightsThe company has grown its December quarter profit by 10.17% from Rs 9.44 crore to Rs 10.40 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Dr. Agarwal's Eye Hospital Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 4,434.93
  • R2
  • 4,817.47
  • R3
  • 5,159.93
Pivot4,092.47
  • S1
  • 3,709.93
  • S2
  • 3,367.47
  • S3
  • 2,984.93
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Dr. Agarwal's Eye Hospital Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Krsnaa Diagnostics
Bearish
744.70-0.282,404.6243.4030.335.17
Shalby
Bearish
188.35-1.052,034.9024.232.030.6322.68
Dr. Agarwal's Eye Hospital
Bearish
4,175.10-0.691,966.4242.5012.580.12157.84
Gpt Healthcare
Bearish
155.15-0.611,277.9127.086.051.248.68
Forbes And Company
Neutral
362.25-467.2580.743.27-3.57
Dr. Agarwal's Eye Hospital Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Dr. Agarwal's Eye Hospital is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 55.45% of shares.
    • InsightsPledging Flat - Promoter(s) pledging has not increased in last quarter.
    • InsightsPromoter(s) holds a high stake in the company at 71.90%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.01 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    WhiteOak Capital Pharma and Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.72
    • % of AUM 0.56
    Dr. Agarwal's Eye Hospital Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-14Quarterly Results
    2024-07-25Quarterly Results
    2024-04-25Audited Results & Final Dividend
    2024-01-18Quarterly Results
    2023-10-20Quarterly Results & Interim Dividend
    About the company Dr. Agarwal's Eye Hospital
    • IndustryHealthcare Facilities
    • ISININE934C01018
    • BSE Code526783
    • NSE Code
    Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
    • Management Info
    • Amar AgarwalExecutive and Non-Independent Chairman of the Board, Managing Director
    • Yashwanth VenkatInterim Chief Financial Officer
    • Meenakshi JayaramanCompliance Officer, Company Secretary
    • Saradha GovindarajanCompliance Officer
    • Athiya AgarwalNon-Independent Whole Time Director
    • S. Lakshmi NarasimhanCompany Secretary
    Dr. Agarwal's Eye Hospital Share Price FAQs

    Dr. Agarwal's Eye Hospital is trading at 4175.10 as on Wed Apr 30 2025 04:39:28. This is -0.69% lower as compared to its previous closing price of 4204.15.

    The market capitalization of Dr. Agarwal's Eye Hospital is 1966.42 Cr as on Wed Apr 30 2025 04:39:28.

    The average broker rating on Dr. Agarwal's Eye Hospital is Strong Buy. The breakup of analyst rating is given below -

    • 1 analysts have given a strong buy rating
    • 0.00 analysts have given a buy rating
    • 0.00 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Dr. Agarwal's Eye Hospital is 7300.00 whereas the 52 wk low is 2800.00

    Dr. Agarwal's Eye Hospital can be analyzed on the following key metrics -

    • TTM P/E: 56.15
    • Sector P/E: 22.89
    • Dividend Yield: 0.12%
    • D/E ratio: -

    Dr. Agarwal's Eye Hospital reported a net profit of 46.36 Cr in 2024.

    The Mutual Fund Shareholding was 0.05% at the end of 31 Dec 2024.